Causes and Treatments of Malignant Glaucoma in the United States
Asahi Fujita(Massachusetts Eye and Ear Infirmary), Anja Lorch(Massachusetts Eye and Ear Infirmary), Tobias Elze, Nazlee Zebardast(Massachusetts Eye and Ear Infirmary), Joan W. Miller(Massachusetts Eye and Ear Infirmary), Connor Ross(Massachusetts Eye and Ear Infirmary), Julia A. Haller(Wills Eye Hospital), Cecilia S. Lee(University of Washington), Yusrah Shweikh(Moorfields Eye Hospital NHS Foundation Trust), Flora Lum(American Academy of Ophthalmology), Leslie Hyman(Stony Brook University Hospital), Aaron Lee(Imperial College London), David Friedman(Massachusetts Eye and Ear Infirmary)
Cited by 1
Related Papers
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
|Nature Medicine|2020|1.2k
Deep Learning Is Effective for Classifying Normal versus Age-Related Macular Degeneration OCT Images
|Ophthalmology Retina|2017|669
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension
|Nature Medicine|2020|665
Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI
|Nature Medicine|2022|636
Genetic variants near <i>TIMP3</i> and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration
|Proceedings of the National Academy of Sciences|2010|518